All News
Cleveland Heartlab Acquired by Quest Diagnostics
Cleveland HeartLab, a Glengary client company and provider of blood and biomarker testing that determines cardiovascular risk, was acquired by Quest Diagnostics. The acquisition provides Quest Diagnostics access to Cleveland HeartLab’s proprietary tests and a strategic collaboration with Cleveland Clinic, while making Cleveland HeartLab its national center of excellence for cardiometabolic disorders.
read more
Cardinal Commerce named Venture of the Year
CardinalCommerce, a Mentor-based fintech firm that was acquired by Visa in December, has been named the 2016 Venture of the Year by the Ohio Venture Association.
Cardinal authenticates payment transactions in what's called the card-not-present payments industry — a channel that's rife with fraud because of the challenges with authenticating its users and transactions. The award was presented on Friday, June 9.
read more
Ohio Venture Community Announces Creation of VentureOhio
Columbus, Ohio – February 20, 2014 – VentureOhio, a newly formed trade association representing
organizations that finance and support entrepreneurs based in Ohio, announced today it will pursue
several key policy initiatives and programs for 2014. These policies will increase early stage capital
availability and promote entrepreneurial growth and job creation in Ohio.“VentureOhio will be a unified voice for the venture investors, incubators, accelerators, universities, and
other organizations that are launching and growing high potential businesses in Ohio,” said John
McIlwraith, VentureOhio Chairman and Allos Ventures Managing Director.
“Venture investment is a long term investment in both time and money,” said Steve Haynes, founding
member of VentureOhio and Chairman of Glengary LLC. “Venture investors are actively engaged with
the companies in which they invest and take a significant role in scaling a small business of two to five
employees to a national or international competitor with hundreds or thousands of employees. When
done well, everyone benefits including customers, employees, shareholders and communities.
For the complete story click here
read more
Cardinal Commerce Receives Two International Patents
Mentor, OH -March 13, 2012- CardinalCommerce, the world-leader in enabling remote commerce (internet, mobile, etc.), today announced that both the Japanese and Canadian Patent Offices have issued patents to Cardinal; numbers 4879431 (JP) and CA 2402382 (CA) respectively. Cardinal's SaaS platforms solve the challenges of brand proliferation, distribution channel expansion, and legacy systems inflexibility across the globe and these patents continue to support and protect Cardinal's novel approach and technology.
"Cardinal's intellectual property portfolio has been significantly strengthened and expanded by adding our seventh and eighth countries with these grants." says Michael A. Keresman, III, President and CEO of CardinalCommerce. "The combination of our intellectual property and established technology capability can provide an IP safe haven and can essentially 'future proof' our Customers' needs."
read more
Neuros Medical Announces Successful Feasibility Study
Cleveland, OH, April 6, 2011 – Neuros Medical, Inc., a medical device company announced promising results today from their recently completed feasibility study. During the study, four of the five patients reported their pain was reduced to zero.
______________________________________________________________________________________
read more
Neuros Medical awarded $300K
Neuros Medical, Inc. received formal confirmation today that their US Army Medical Research Acquisition Activity (USAMRAA) grant proposal for $300k was selected for award! Added to the DOD award of $1.5 million, this brings a total of $1.8 million in non-dilutive funding to Neuros.
read more
Neuros Medical Award $1.5M from US Dept. of Defense
July 1, 2010 – Neuros Medical, Inc., announced the Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP). The funding will aid technology development and human clinical research for their neurostimulation therapy, called Nerve Block, focusing on the treatment of chronic residual limb pain which is suffered by nearly one million amputees.
read more
CardinalCommerce receives patent approval
Mentor Ohio- CardinalCommerce, the world-leading enabler of payment brands, today announced that the US Patent and Trademark Office (USPTO) issued patent number US 7,742,967, which covers fundamental aspects to secure payment processing.
read more
Neuros Medical goal: no more pain meds
People who suffer from chronic pain could someday toss their painkillers into the garbage for good. Neuros Medical is developing a device that uses an electrode to deliver high-frequency stimulation to sensory nerves in the peripheral nervous system. Basically, pain signals in the spine just won't make it to the brain.
read more
Glengary Completes Initial Close for Investors
Glengary LLC announced it has completed an initial closing of a round of institutional fundraising on December 28, with commitments from National City Bank, KeyBank, The Fred A. Lennon Charitable Trust, The Huntington National Bank and Baldwin-Wallace College, among others.
read more